Xeris Biopharma Holdings, Inc. XERS Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Corcept TherapeuticsCORT

1.1%-19.0pp

Eton Pharmaceuticals, Inc.ETON

-45.1%-22.2pp

Zevra Therapeutics, Inc.ZVRA

71.7%+48.7pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

ANI PharmaceuticalsANIP

21.3%+21.3pp

FAQ

What is Xeris Biopharma Holdings, Inc.'s return on invested capital?

Xeris Biopharma Holdings, Inc. (XERS) reported return on invested capital of 21.7% in Q2 2026.

How has Xeris Biopharma Holdings, Inc.'s return on invested capital changed year-over-year?

Xeris Biopharma Holdings, Inc.'s return on invested capital increased by 451.2% year-over-year, from -6.2% to 21.7%.

What is the long-term trend for Xeris Biopharma Holdings, Inc.'s return on invested capital?

Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s return on invested capital has grown at a -39.9% compound annual growth rate (CAGR), from -115.6% to 15%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.